Mudumbi R V, Montamat S C, Bruns R F, Vestal R E
Clinical Pharmacology and Gerontology Research Unit, Veterans Affairs Medical Center, Boise, Idaho 83702.
Am J Physiol. 1993 Mar;264(3 Pt 2):H1017-22. doi: 10.1152/ajpheart.1993.264.3.H1017.
Adenosine, a locally released and rapidly metabolized nucleoside, protects the heart from damage during ischemia by reducing oxygen demand and increasing oxygen supply. The aminothiophene derivative (2-amino-4,5-dimethylthien-3-yl)[3-(trifluoromethyl)phenyl]-met hanone (PD 81,723) has been shown to act as an allosteric enhancer of the adenosine A1 receptor in brain membranes and thyroid cells. The present study investigates the effects of PD 81,723 in spontaneously contracting right atria and electrically stimulated left atria isolated from Sprague-Dawley rats. N6-cyclopentyladenosine (CPA), an adenosine A1 receptor agonist, produced concentration-dependent inhibition of heart rate in right atria and contractile parameters in left atria. In the right atrium, 5 microM of PD 81,723 significantly shifted the concentration-response curves for CPA to the left, both in the absence and presence of a nonselective adenosine receptor antagonist, 8-(p-sulfophenyl)theophylline (8-SPT, 10 microM). In the left atrium, PD 81,723 also shifted the concentration-response curves for CPA to the left, but only in the presence of 8-SPT. Potentiation of CPA-induced negative chronotropic and inotropic responses with PD 81,723, although not significant, was also observed in the presence of a selective adenosine A1 receptor antagonist, 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 1 nM). These results demonstrate that PD 81,723 enhances the direct negative chronotropic and inotropic effects of adenosine A1 receptor activation in rat atria.
腺苷是一种局部释放且迅速代谢的核苷,通过降低氧需求和增加氧供应来保护心脏在缺血期间免受损伤。氨基噻吩衍生物(2-氨基-4,5-二甲基噻吩-3-基)[3-(三氟甲基)苯基]甲酮(PD 81,723)已被证明在脑膜和甲状腺细胞中作为腺苷A1受体的变构增强剂起作用。本研究调查了PD 81,723对从Sprague-Dawley大鼠分离的自发收缩右心房和电刺激左心房的影响。N6-环戊基腺苷(CPA),一种腺苷A1受体激动剂,在右心房产生浓度依赖性的心率抑制和左心房收缩参数抑制。在右心房,5微摩尔的PD 81,723在不存在和存在非选择性腺苷受体拮抗剂8-(对磺基苯基)茶碱(8-SPT,10微摩尔)的情况下,均显著将CPA的浓度-反应曲线向左移动。在左心房,PD 81,723也将CPA的浓度-反应曲线向左移动,但仅在存在8-SPT时。在存在选择性腺苷A1受体拮抗剂1,3-二丙基-8-环戊基黄嘌呤(DPCPX,1纳摩尔)的情况下,也观察到PD 81,723对CPA诱导的负性变时性和变力性反应的增强作用,尽管不显著。这些结果表明,PD 81,723增强了腺苷A1受体激活在大鼠心房中的直接负性变时性和变力性作用。